The Birmingham Epidermolysis Bullosa Severity (BEBS) score of EB patients

What is EB? - EB-Research

Dystrophic Epidermolysis Bullosa in a Preschooler in a Middle Eastern Country - Harshita Prabhakaran, Judie Arulappan, Sheeba Elizabeth J, Sophia Cyril Vincent, 2023

A comparison study of outcome measures for epidermolysis bullosa: Epidermolysis Bullosa Disease Activity and Scarring Index (EBDASI) and the Instrument for Scoring Clinical Outcomes of Research for Epidermolysis Bullosa (iscorEB). - Abstract

PDF) Epidermolysis bullosa simplex generalized severe induces a T helper 17 response and is improved by apremilast treatment

Dystrophic Epidermolysis Bullosa in a Preschooler in a Middle Eastern Country - Harshita Prabhakaran, Judie Arulappan, Sheeba Elizabeth J, Sophia Cyril Vincent, 2023

PDF) Birmingham epidermolysis severity score and vitamin D status are associated with low BMD in children with epidermolysis bullosa

Social/economic costs and health-related quality of life in patients with epidermolysis bullosa in Europe

Clinical and molecular studies in two patients with dystrophic epidermolysis bullosa - Indian Journal of Dermatology, Venereology and Leprology

Hindi translation and validation of quality of life score in Indian patients with epidermolysis bullosa; and its correlation with the clinical severity assessment scores: A cross-sectional study - Indian Journal of Dermatology